University Hospital Gent

The trials here

What the 14 trials at this site are about, from their registry records.

Conditions

• Childhood cancers2 trials
• Duchenne muscular dystrophy2 trials
• Acute lymphoblastic leukaemia1 trial
• Acute myeloid leukaemia1 trial
• Alzheimer disease1 trial
• Bladder cancer1 trial
• Endometrial cancer1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Gastric and oesophageal cancer1 trial
• Head and neck cancer1 trial
• Lung cancer1 trial
• Pancreatic cancer1 trial
• and 1 more

Phase

• Phase 24 trials
• Phase 34 trials
• Phase 1/21 trial

Status

• Completed5 trials
• Recruiting3 trials
• Active, not recruiting2 trials
• Enrolling by invitation1 trial
• Not yet recruiting1 trial
• Suspended1 trial
• Terminated1 trial

Lead sponsor

• Edgewise Therapeutics, Inc.2 trials
• Universitaire Ziekenhuizen KU Leuven2 trials
• University Hospital, Ghent2 trials
• BicycleTx Limited1 trial
• European Organisation for Research and Treatment of Cancer - EORTC1 trial
• and 6 more

Running trials

• Recruiting

  Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults

  NCT07727694· Universitaire Ziekenhuizen KU Leuven· Source

  Contact: Bram De Wilde, MD

• Recruiting

  Spatial Navigation for the Early Detection of Alzheimer's Disease.

  NCT06385951· University Hospital, Ghent· Source

  Contact: Tineke Van Vrekhem

• Active, not recruiting

  Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

  NCT06225596· Phase 2· BicycleTx Limited· Source

• Enrolling by invitation

  Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy

  NCT06066580· Phase 2· Edgewise Therapeutics, Inc.· Source

• Recruiting

  Comparison Between the Efficacy of Residential and Ambulatory Weight Loss Programs for Pediatric Non-alcoholic Fatty Liver Disease

  NCT05309863· University Hospital, Ghent· Source

  Contact: Ruth De Bruyne, MD, PhD

• Recruiting

  Dose De-escalation and Sentinel LN Mapping Driven Radiotherapy of Contralateral Neck in Ipsilateral Node Positive HNSCC

  NCT04688528· Universitaire Ziekenhuizen KU Leuven· Source

  Contact: Frederic Duprez

• Active, not recruiting

  PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer

  NCT03469674· Phase 3· Leiden University Medical Center· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease1 recruiting
• Childhood cancers1 recruiting
• Duchenne muscular dystrophy1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Head and neck cancer1 recruiting

Closed trials

• Completed

  Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)

  NCT05291091· Phase 2· Edgewise Therapeutics, Inc.· Source

• Terminated

  Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia

  NCT05079230· Phase 3· Gilead Sciences· Source

• Completed

  Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy

  NCT04447118· Phase 3· Jiangsu HengRui Medicine Co., Ltd.· Source

• Completed

  A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

  NCT04083235· Phase 3· Ipsen· Source

• Completed

  Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

  NCT02625480· Phase 1/2· Kite, A Gilead Company· Source

• Completed

  Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma

  NCT02205047· Phase 2· European Organisation for Research and Treatment of Cancer - EORTC· Source